HUT70566A - Method for treating endotoxin shock using antiadhesion antibodies - Google Patents

Method for treating endotoxin shock using antiadhesion antibodies

Info

Publication number
HUT70566A
HUT70566A HU9300538A HU53893A HUT70566A HU T70566 A HUT70566 A HU T70566A HU 9300538 A HU9300538 A HU 9300538A HU 53893 A HU53893 A HU 53893A HU T70566 A HUT70566 A HU T70566A
Authority
HU
Hungary
Prior art keywords
antiadhesion
antibodies
endotoxin shock
treating endotoxin
treating
Prior art date
Application number
HU9300538A
Other languages
English (en)
Other versions
HU216097B (hu
HU9300538D0 (en
Inventor
Lindsay Gordon Letts
Steven M Weldon
Genus J Possanza
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of HU9300538D0 publication Critical patent/HU9300538D0/hu
Publication of HUT70566A publication Critical patent/HUT70566A/hu
Publication of HU216097B publication Critical patent/HU216097B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2821—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against ICAM molecules, e.g. CD50, CD54, CD102
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2845—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HUP9300538A 1990-08-31 1991-08-30 Eljárás endotoxinsokk kezelésére antiadhéziós antitestek alkalmazásával HU216097B (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57913790A 1990-08-31 1990-08-31

Publications (3)

Publication Number Publication Date
HU9300538D0 HU9300538D0 (en) 1993-05-28
HUT70566A true HUT70566A (en) 1995-10-30
HU216097B HU216097B (hu) 1999-04-28

Family

ID=24315708

Family Applications (1)

Application Number Title Priority Date Filing Date
HUP9300538A HU216097B (hu) 1990-08-31 1991-08-30 Eljárás endotoxinsokk kezelésére antiadhéziós antitestek alkalmazásával

Country Status (11)

Country Link
EP (1) EP0546076B1 (hu)
JP (1) JPH06501931A (hu)
AT (1) ATE166230T1 (hu)
AU (1) AU645348B2 (hu)
CA (1) CA2090464A1 (hu)
DE (1) DE69129460T2 (hu)
DK (1) DK0546076T3 (hu)
ES (1) ES2115618T3 (hu)
HU (1) HU216097B (hu)
RU (1) RU2123861C1 (hu)
WO (1) WO1992004034A1 (hu)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5891841A (en) * 1991-06-11 1999-04-06 The Center For Blood Research, Inc. Methods of using intercellular adhesion molecule-3 (ICAM-3), antibodies thereto, and soluble fragments thereof
GB9115364D0 (en) * 1991-07-16 1991-08-28 Wellcome Found Antibody
US5702917A (en) * 1992-01-27 1997-12-30 Icos Corporation Polynucleotides encoding human ICAM-4
US5880268A (en) * 1992-01-27 1999-03-09 Icos Corporation Modulators of the interaction between ICAM-R and αd /CD18
US5852170A (en) * 1992-01-27 1998-12-22 Icos Corporation ICAM-4 materials and methods
US6818743B1 (en) 1992-01-27 2004-11-16 Icos Corporation I-CAM related protein
US5837822A (en) * 1992-01-27 1998-11-17 Icos Corporation Humanized antibodies specific for ICAM related protein
US5773293A (en) * 1992-01-27 1998-06-30 Icos Corporation Anti-ICAM-4 antibodies and hybridomas
US5525487A (en) * 1992-01-27 1996-06-11 Icos Corporation DNA encoding I-CAM related protein
US5753502A (en) * 1993-08-05 1998-05-19 Icos Corporation Neuron-specific ICAM-4 promoter
US5989843A (en) * 1992-01-27 1999-11-23 Icos Corporation Methods for identifying modulators of protein kinase C phosphorylation of ICAM-related protein
US6153395A (en) * 1992-01-27 2000-11-28 Icos Corporation ICAM-related protein
WO1993014776A1 (en) * 1992-01-27 1993-08-05 Icos Corporation Icam-related protein
US5532127A (en) * 1992-01-27 1996-07-02 Icos Corporation Assay for 1-CAM related protein expression
US6100383A (en) * 1992-01-27 2000-08-08 Icos Corporation Fusion proteins comprising ICAM-R polypeptides and immunoglobulin constant regions
US5700658A (en) * 1992-01-27 1997-12-23 Icos Corporation ICAM-4 materials and methods
US5854070A (en) * 1992-07-16 1998-12-29 Icos Corporation Murine and humanizer 23F2G antibodies and cell lines expressing said antibodies
EP0604647A4 (en) 1992-07-16 1996-09-25 Icos Corp Alleviation of symptoms associated with inflammatory disease states.
JPH08500826A (ja) * 1992-08-21 1996-01-30 ジェネンテク，インコーポレイテッド Ｌｆａ−１仲介疾患を処置する方法
US5695760A (en) * 1995-04-24 1997-12-09 Boehringer Inglehiem Pharmaceuticals, Inc. Modified anti-ICAM-1 antibodies and their use in the treatment of inflammation
JP3813450B2 (ja) * 2000-02-29 2006-08-23 古河電気工業株式会社 半導体レーザ素子
RU2336897C1 (ru) * 2007-04-28 2008-10-27 Федеральное государственное учреждение здравоохранения "Ростовский-на-Дону научно-исследовательский противочумный институт" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека Способ терапии токсического шока у лабораторных животных при экспериментальной чуме

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0061174B1 (de) * 1981-03-25 1985-01-16 Windmöller & Hölscher Verfahren und Vorrichtung zum Einlegen einer Schlauchbahn unter Ausbildung von Z-Falten in einen Rundgewebeschlauch
US4388318A (en) * 1981-09-29 1983-06-14 Boehringer Ingelheim International Gmbh Method of treating endotoxin shock with a pyrimido-pyrimidine derivative
US4472420A (en) * 1983-08-18 1984-09-18 Methodist Hospital Of Indiana, Inc. Method for treatment of shock
ATE114972T1 (de) * 1987-11-02 1994-12-15 Baylor College Medicine Verwendung von icam-1 oder ihre funktionelle derivate zur behandlung unspezifischer entzündungen.
US5147637A (en) * 1988-06-07 1992-09-15 The Rockefeller University Method of inhibiting the influx of leukocytes into organs during sepsis or other trauma
US5176908A (en) * 1988-12-19 1993-01-05 American Cyanamid Company Method for the treatment of endotoxic shock in mammal
ES2096553T3 (es) * 1988-12-19 1997-03-16 American Cyanamid Co Metodo para el tratamiento de choque endotoxico en un animal mamifero.

Also Published As

Publication number Publication date
DE69129460T2 (de) 1998-10-15
HU216097B (hu) 1999-04-28
CA2090464A1 (en) 1992-03-01
ES2115618T3 (es) 1998-07-01
HU9300538D0 (en) 1993-05-28
DE69129460D1 (de) 1998-06-25
DK0546076T3 (da) 1998-10-19
ATE166230T1 (de) 1998-06-15
EP0546076A4 (en) 1993-08-04
WO1992004034A1 (en) 1992-03-19
RU2123861C1 (ru) 1998-12-27
JPH06501931A (ja) 1994-03-03
EP0546076B1 (en) 1998-05-20
AU645348B2 (en) 1994-01-13
AU8502791A (en) 1992-03-30
EP0546076A1 (en) 1993-06-16

Similar Documents

Publication Publication Date Title
HUT70566A (en) Method for treating endotoxin shock using antiadhesion antibodies
EA200200503A1 (ru) Способ лечения ревматоидного артрита
CA2025597A1 (en) Vaccine against lyme disease
ES2106195T3 (es) Anticuerpo igg aglicosilado anti cd3.
HU9203370D0 (en) Humanized chimaeric anti-icam-1 antibodies and method for producing them
RU93004982A (ru) Способ лечения эндотоксинового шока с применением антиадгезивных антител
DE3167698D1 (en) Method for the determination of antigens with the aid of two or more monoclonal antibodies
NO910333D0 (no) Fremgangsmaate for plasmasprengning.
AU4485493A (en) Method for generating monoclonal antibodies from rabbits
MX9603080A (es) Anticuerpos monoclonales inmuno-estimulantes.
DK0482176T3 (da) Monoklonale antistoffer, der er specifikke for Toxin B Fra Clostridium difficile
PT840618E (pt) Inducao de tolerancia imunologica atraves de anticorpos anti-cd4 nao-depletores
GB8910263D0 (en) Monoclonal antibodies specific for an immunoglobulin isotype
AU4441393A (en) Granulocyte-binding antibody fragments, their preparation and use
SE9201281D0 (sv) New human monoclonal antibodies, and a method for preparation thereof
ES2089449T3 (es) Nuevo procedimiento de preparacion de hidrocortisona y nuevos productos intermedios.
EP0627934A4 (en) EARLY ANTIGEN FOR AUTOIMMUNE DIABETE.
DE3570677D1 (en) Acino-foetal differentiation proteins associated with cancer of the pancreas, antiserum and monoclonal antibodies against these proteins and processes for their preparation
NO834535L (no) Fremgangsmaate for affinitetsrensing under anvendelse av monoklonale antistoffer.
WO1992004464A3 (en) Monoclonal antibodies against tenascin
HUT62803A (en) Process for producing antigen-specific, high affinity human monoclonal antibody
HUT75824A (en) A novel endothelial cell molecule mediating lymphocyte binding in man
EP0034543A3 (en) Process for solubilization of gonococcal antigen
NO894555D0 (no) Monoklonalt antistoff som spesifikt gjenkjenner n-glycolyl type gm2, hybridom som produserer antistoff og fremgangsmaate for fremstilling av hybridomet.
EP0512023A4 (en) Medicaments and methods for treating aids and arc employing anti-carbohydrate antibodies and carbohydrate antigens

Legal Events

Date Code Title Description
HMM4 Cancellation of final prot. due to non-payment of fee